ArticleNPJ Parkinson's disease2026
Post-gadolinium T1 alterations in Parkinson's disease and essential tremor.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Post-contrast T1 changes (ΔT1) on brain MRI may reflect alterations in cerebrospinal fluid dynamics and microvascular exchange in movement disorders. We investigated regional post-contrast ΔT1 differences in patients with idiopathic Parkinson's disease (IPD) and essential tremor (ET). In this retrospective single-center study, 277 patients who underwent brain MRI for suspected movement disorders between November 2023 and February 2025 were classified as ET (n = 109), early IPD (n = 81), or advanced IPD (n = 87). Post-contrast ΔT1 values were calculated by subtracting pre-contrast from post-contrast T1 measurements in the choroid plexus (CP), basal ganglia perivascular spaces, cerebral cortex, cerebellar cortex, and thalamus. Advanced IPD demonstrated significantly greater T1 shortening in the CP compared with ET, while showing reduced T1 shortening in the cerebellar cortex and thalamus. No significant differences were observed in other regions. These findings suggest region-specific alterations in contrast kinetics in advanced IPD, potentially reflecting disease-related changes in contrast distribution and microvascular permeability. Quantitative post-contrast T1 mapping may provide complementary imaging markers for distinguishing Parkinson's disease from essential tremor.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.